[{"NetIncomeLossConverted_1_Q2_USD":149456000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":222250000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":222061000.0,"CommonStockSharesConverted_0_Q2_shares":220424569.0,"Assets_0_Q2_USD":3904623000.0,"RevenuesConverted_2_Q2_USD":1310427000.0,"RevenuesConverted_1_Q2_USD":705709000.0,"EarningsPerShareBasic_2_Q2_USD":0.92,"StockholdersEquity_0_Q2_USD":2935861000.0,"EarningsPerShareDiluted_2_Q2_USD":0.91,"EarningsPerShareDiluted_1_Q2_USD":0.67,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":379039000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":219942000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":220083000.0,"NetIncomeLossConverted_2_Q2_USD":202991000.0,"CommonStockSharesOutstanding_0_Q2_shares":220424569.0,"EarningsPerShareBasic_1_Q2_USD":0.68,"Ticker":"INCY","CIK":"879169","name":"INCYTE CORP","OfficialName":"Incyte Corp. Common Stock","form":"10-Q","period":"20210630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"17588712770.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"SP500","filed":"20210803"}]